Cart summary

You have no items in your shopping cart.

AZD4625

SKU: orb1686805

Description

AZD4625 is a potent, selective, and orally bioavailable covalent inhibitor targeting the oncogenic mutant KRAS G12C. It demonstrates activity in both cellular assays and in vivo models, supporting its use in cancer research, particularly for studying targeted therapies in KRAS-driven tumors.

Research Area

Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

MW486.9
FormulaC24H21ClF2N4O3
TargetKras,Others,Ras

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • AZD4625 [orb1818626]

    0.98

    486.904

    C24H21ClF2N4O3

    5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

AZD4625 (orb1686805)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%